Quarterly Results

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE433.002.9 (+0.67 %)
PREV CLOSE ( ) 430.10
OPEN PRICE ( ) 434.30
BID PRICE (QTY) 433.00 (328)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 87834
TODAY'S LOW / HIGH ( )430.05 439.20
52 WK LOW / HIGH ( )279.65 470.9
NSE433.103.05 (+0.71 %)
PREV CLOSE( ) 430.05
OPEN PRICE ( ) 432.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1185359
TODAY'S LOW / HIGH( ) 430.00 439.05
52 WK LOW / HIGH ( )278.85 471
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
11949.2
12244.5
11817.9
13809
Total Expenditure
10135
10365.8
10150.7
10953.6
PBIDT (Excl OI)
1814.2
1878.7
1667.2
2855.4
Other Income
24.3
17.8
36
17.1
Operating Profit
1838.5
1896.5
1703.2
2872.5
Interest
508.2
423.9
391.9
531
Exceptional Items
NA
NA
NA
NA
PBDT
1330.3
1472.6
1311.3
2341.5
Depreciation
984.1
933.7
905.5
870.1
Profit Before Tax
346.2
538.9
405.80
1471.4
Tax
94.5
145.7
121.8
399
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
251.7
393.2
284.00
1072.4
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
251.7
393.2
284.00
1072.4
Minority Interest
-2
-1.7
-19.4
-22.9
Shares of Associates
-18.3
-22
-16.1
-19.7
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
231.4
369.5
248.5
1029.8
Equity Capital
1077.9
1077.3
1077.3
1077.3
Face Value (IN RS)
2
2
2
2
Reserves
NA
NA
NA
NA
Calculated EPS
0.42
0.68
0.46
1.91
Calculated EPS (Annualised)
1.71
2.74
1.84
7.64
No of Public Share Holdings
392447262
392132329
392132329
392132329
% of Public Share Holdings
72.81
72.8
72.8
72.8
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
15.18
15.34
14.10
20.67
PBIDTM%
15.38
15.48
14.41
20.80
PBDTM%
11.13
12.02
11.09
16.95
PBTM%
2.89
4.40
3.43
10.65
PATM%
2.10
3.21
2.40
7.76
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.